Skip to main content
NCBI home page
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
. 2009 Jul 13;68(3):110–117. doi: 10.1016/S1726-4901(09)70231-X

Clinical Characteristics, Management and Prognostic Factors in Patients with Probable Severe Acute Respiratory Syndrome (SARS) in a SARS Center in Taiwan

Chun-Yu Liu a, Lin-Ju Huang b, Chung-Hsu Lai b, Hsin-Pai Chen b, Te-Li Chen b,c,*, Chang-Phone Fung b,c, Cheng-Yi Li b,c
PMCID: PMC7128227  PMID: 15813244

Abstract

Background

Severe acute respiratory syndrome (SARS) is an emerging viral infectious disease. We report our experience in treating SARS patients.

Methods

From April 27 to May 24, 2003, a total of 36 patients with probable SARS were admitted and treated in a hospital rearranged as a special center for the management of SARS patients. Medical records for the patients were retrospectively reviewed. Univariate and multivariate analyses were performed to determine factors associated with respiratory failure and intubation.

Results

Of the 36 patients with probable SARS (median age, 37 years; range, 22-66 years), 9 were male and 27 were female. Thirty-two patients (88.9%) were infected in the hospital setting. All patients presented with fever, and 33 eventually developed lymphopenia during hospitalization. Chest radiography showed no unique pattern, but pleural effusion was not seen. All patients initially received empiric antibacterial therapy against common causative pathogens of atypical pneumonia. Ribavirin was given to all except 1 patient. Twenty-two patients received immunoglobulin therapy, and 32 were given corticosteroids. A total of 20 patients (55.6%) required supplemental oxygen, and 8 (22.2%) were intubated with mechanical ventilatory support. Two of these patients died. A higher body temperature at presentation (median 39.5 vs 38.6°C), and higher peak values of lactate dehydrogenase (410 vs 282 U/L) and C-reactive protein (10.2 vs 2.5 mg/dL), were associated with subsequent respiratory failure. Multivariate analysis showed that peak level of C-reactive protein was the only independent predictor of respiratory failure and intubation (odds ratio for every increment of 1 mg/dL = 1.45; 95% confidence interval = 1.003, 2.097; p = 0.048).

Conclusion

All patients with probable SARS who were admitted to hospital presented with fever and lymphopenia. While the efficacy of different treatments could not be evaluated from this retrospective study, a higher value of C-reactive protein was associated with the development of respiratory failure and subsequent intubation.

Key Words: clinical characteristics, C-reactive protein, prognostic factors, severe acute respiratory syndrome (SARS)

References

  • 1.World Health Organization. Acute respiratory syndrome in China update 3: disease outbreak reported. Geneva: World Health Organization, 2003. Available at URL: http://www.who.int/csr/don/2003_2_20/en [Accessed: March 31, 2003]
  • 2.World Health Organization. Cumulative number of reported probable cases of SARS from 1 November 2002 to 31 May 2003. Geneva: World Health Organization, 2003. Available at URL: http://www.who.int/csr/sars/country/2003_05_31/en [Accessed: May 31, 2003]
  • 3.Twu SJ, Chen TJ, Chen CJ, Olsen SJ, Lee LT, Fisk T, Hsu KH. Control measures for severe acute respiratory syndrome (SARS) in Taiwan. Emerg Infect Dis. 2003;9:718–720. doi: 10.3201/eid0906.030283. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Wong WW, Chen TL, Yang SP, Wang FD, Cheng NC, Kuo BI, Yu KW. Clinical characteristics of fatal patients with severe acute respiratory syndrome in a medical center in Taipei. J Chin Med Assoc. 2003;66:323–327. [PubMed] [Google Scholar]
  • 5.Chiang CH, Chen HM, Shih JF, Su WJ, Perng RP. Management of hospital-acquired severe acute respiratory syndrome with different disease spectrum. J Chin Med Assoc. 2003;66:328–338. [PubMed] [Google Scholar]
  • 6.Wang YH, Lin AS, Chao TY, Lu SN, Liu JW, Chen SS, Lin MC. A cluster of patients with severe acute respiratory syndrome in a chest ward in southern Taiwan. Intensive Care Med. 2004;30:1228–1231. doi: 10.1007/s00134-004-2311-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Wang JT, Sheng WH, Fang CT, Chen YC, Wang JL, Yu CJ, Chang SC. Clinical manifestations, laboratory findings, and treatment outcomes of SARS patients. Emerg Infect Dis. 2004;10:818–824. doi: 10.3201/eid1005.030640. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Jang TN, Yeh DY, Shen SH, Huang CH, Jiang JS, Kao SJ. Severe acute respiratory syndrome in Taiwan: analysis of epidemiological characteristics in 29 cases. J Infect. 2004;48:23–31. doi: 10.1016/j.jinf.2003.09.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.World Health Organization . Case definitions for surveillance of severe acute respiratory syndrome (SARS) World Health Organization; Geneva: 2003. Available at URL: http://www.who.int/csr/sars/casedefinition/en/ [Accessed: May 1, 2003] [Google Scholar]
  • 10.Rainer TH, Cameron PA, Smit D, Ong KL, Hung AN, Nin DC, Ahuja AT. Evaluation of WHO criteria for identifying patients with severe acute respiratory syndrome out of hospital: prospective observational study. BMJ. 2003;326:1354–1358. doi: 10.1136/bmj.326.7403.1354. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Booth CM, Matukas LM, Tomlinson GA, Rachlis AR, Rose DB, Dwosh HA, Walmsley SL. Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. JAMA. 2003;289:2801–2809. doi: 10.1001/jama.289.21.JOC30885. [DOI] [PubMed] [Google Scholar]
  • 12.Lee N, Hui D, Wu A, Chan P, Cameron P, Joynt GM, Ahuja A. A major outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med. 2003;348:1986–1994. doi: 10.1056/NEJMoa030685. [DOI] [PubMed] [Google Scholar]
  • 13.Peiris JS, Chu CM, Cheng VC, Chan KS, Hung IF, Poon LL, Law KI. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet. 2003;361:1767–1772. doi: 10.1016/S0140-6736(03)13412-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Wong RS, Wu A, To KF, Lee N, Lam CW, Wong CK, Chan PK. Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis. BMJ. 2003;326:1358–1362. doi: 10.1136/bmj.326.7403.1358. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Panesar NS. Lymphopenia in SARS. Lancet. 2003;361:1985. doi: 10.1016/S0140-6736(03)13557-X. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.O'Donnell R, Tasker RC, Roe MF. SARS: understanding the coronavirus: apoptosis may explain lymphopenia of SARS. BMJ. 2003;327:620. doi: 10.1136/bmj.327.7415.620-b. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Wong KT, Antonio GE, Hui DS, Lee N, Yuen EH, Wu A, Leung CB. Severe acute respiratory syndrome: radiographic appearances and pattern of progression in 138 patients. Radiology. 2003;228:401–406. doi: 10.1148/radiol.2282030593. [DOI] [PubMed] [Google Scholar]
  • 18.Zhao Z, Zhang F, Xu M, Huang K, Zhong W, Cai W, Yin Z. Description and clinical treatment of an early outbreak of severe acute respiratory syndrome (SARS) in Guangzhou, PR China. J Med Microbiol. 2003;52:715–720. doi: 10.1099/jmm.0.05320-0. [DOI] [PubMed] [Google Scholar]
  • 19.Muller NL, Ooi GC, Khong PL, Nicolaou S. Severe acute respiratory syndrome: radiographic and CT findings. AJR Am J Roentgenol. 2003;181:3–8. doi: 10.2214/ajr.181.1.1810003. [DOI] [PubMed] [Google Scholar]
  • 20.Grinblat L, Shulman H, Glickman A, Matukas L, Paul N. Severe acute respiratory syndrome: radiographic review of 40 probable cases in Toronto, Canada. Radiology. 2003;228:802–809. doi: 10.1148/radiol.2283030671. [DOI] [PubMed] [Google Scholar]
  • 21.Konoplev S, Champlin RE, Giralt S, Ueno NT, Khouri I, Raad I, Rolston K. Cytomegalovirus pneumonia in adult autologous blood and marrow transplant recipients. Bone Marrow Transplant. 2001;27:877–881. doi: 10.1038/sj.bmt.1702877. [DOI] [PubMed] [Google Scholar]
  • 22.Ghosh S, Champlin RE, Englund J, Giralt SA, Rolston K, Raad I, Jacobson K. Respiratory syncytial virus upper respiratory tract illnesses in adult blood and marrow transplant recipients: combination therapy with aerosolized ribavirin and intravenous immunoglobulin. Bone Marrow Transplant. 2000;25:751–755. doi: 10.1038/sj.bmt.1702228. [DOI] [PubMed] [Google Scholar]
  • 23.Ghosh S, Champlin RE, Ueno NT, Anderlini P, Rolston K, Raad I, Kontoyiannis D. Respiratory syncytial virus infections in autologous blood and marrow transplant recipients with breast cancer: combination therapy with aerosolized ribavirin and parenteral immunoglobulins. Bone Marrow Transplant. 2001;28:271–275. doi: 10.1038/sj.bmt.1703131. [DOI] [PubMed] [Google Scholar]
  • 24.Wandstrat TL. Respiratory syncytial virus immune globulin intravenous. Ann Pharmacother. 1997;31:83–88. doi: 10.1177/106002809703100114. [DOI] [PubMed] [Google Scholar]
  • 25.Shirai T, Sano K, Matsuyama S, Honjo Y, Takashima M, Sasada Y, Takayanagi S. Varicella pneumonia in a healthy adult presenting with severe respiratory failure. Intern Med. 1996;35:315–318. doi: 10.2169/internalmedicine.35.315. [DOI] [PubMed] [Google Scholar]
  • 26.Sabroe I, McHale J, Tait DR, Lynn WA, Ward KN, Shaunak S. Treatment of adenoviral pneumonitis with intravenous ribavirin and immunoglobulin. Thorax. 1995;50:1219–1220. doi: 10.1136/thx.50.11.1219. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Tokat O, Kelebek N, Turker G, Kahveci SF, Ozcan B. Intravenous immunoglobulin in adult varicella pneumonia complicated by acute respiratory distress syndrome. J Int Med Res. 2001;29:252–255. doi: 10.1177/147323000102900313. [DOI] [PubMed] [Google Scholar]
  • 28.World Health Organization. Update 49 - SARS case fatality ratio, incubation period. Geneva: World Health Organization, 2003. Available at URL: http://www.who.int/csr/sars/archive/2003_05_07a/en/ [Accessed: May 7, 2003]
  • 29.Ablij H, Meinders A. C-reactive protein: history and revival. Eur J Intern Med. 2002;13:412. doi: 10.1016/s0953-6205(02)00132-2. [DOI] [PubMed] [Google Scholar]
  • 30.Ortqvist A, Hedlund J, Wretlind B, Carlstrom A, Kalin M. Diagnostic and prognostic value of interleukin-6 and C-reactive protein in community-acquired pneumonia. Scand J Infect Dis. 1995;27:457–462. doi: 10.3109/00365549509047046. [DOI] [PubMed] [Google Scholar]
  • 31.Lobo SM, Lobo FR, Bota DP, Lopes-Ferreira F, Soliman HM, Melot C, Vincent JL. C-reactive protein levels correlate with mortality and organ failure in critically ill patients. Chest. 2003;123:2043–2049. doi: 10.1378/chest.123.6.2043. [DOI] [PubMed] [Google Scholar]

Articles from Journal of the Chinese Medical Association are provided here courtesy of Elsevier

RESOURCES